Keshia Kroh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Keshia Kroh has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Carmen W. E. Embregts
Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands
2 shared publications - Corine H. GeurtsvanKessel
Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands
2 shared publications - Debby Schipper
Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands
2 shared publications - Redwan Rahmat
Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands
2 shared publications Alisha D. Biharie
Department of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands
1 shared publication- Ariane Neumann
Lund University
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (9) , 002318
Langerhans cells as targets of rabies virus immune evasion
Rabies virus (RABV) is a neurotropic virus of the genus Lyssavirus that causes a nearly always fatal encephalitis in humans once it reaches the central nervous system. Dog bites are a major transmission route of RABV, and following superficial skin exposure, RABV first encounters epidermal Langerhans cells (LCs), yet their role in early infection remains poorly understood. Here, we show that exposure of immature human epidermal LCs to RABV leads to RABV association with cells in the absence of productive viral replication. RABV-exposed LCs display reduced cytokine and type I IFN responses and lack induction of IFN-stimulated genes, indicating suppression of antiviral signalling pathways. Together, these findings suggest that RABV is efficiently taken up by immature LCs, which dampens the antiviral immune responses of LCs, potentially facilitating immune evasion at the skin entry site.
- 17 September 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (9) , 002318
Open AccessLangerhans cells as targets of rabies virus immune evasion
Rabies virus (RABV) is a neurotropic virus of the genus Lyssavirus that causes a nearly always fatal encephalitis in humans once it reaches the central nervous system. Dog bites are a major transmission route of RABV, and following superficial skin exposure, RABV first encounters epidermal Langerhans cells (LCs), yet their role in early infection remains poorly understood. Here, we show that exposure of immature human epidermal LCs to RABV leads to RABV association with cells in the absence of productive viral replication. RABV-exposed LCs display reduced cytokine and type I IFN responses and lack induction of IFN-stimulated genes, indicating suppression of antiviral signalling pathways. Together, these findings suggest that RABV is efficiently taken up by immature LCs, which dampens the antiviral immune responses of LCs, potentially facilitating immune evasion at the skin entry site.
- Open Access
- 16 April 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (8) , 2255-2266.e5
Rabies virus infection and immune activation in human epidermal keratinocytes: Implications for rabies transmission
- 16 April 2026
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (8) , 2255-2266.e5
Open AccessRabies virus infection and immune activation in human epidermal keratinocytes: Implications for rabies transmission
- Open Access
- 6 November 2025
- Published by Microbiology Society in Journal of General Virology
- Vol. 106 (11) , 002166
Immunohistochemical investigation of canine lymph nodes collected during a rabies outbreak in South Africa
Rabies is a fatal zoonosis that impairs host immune function, yet effects on peripheral lymphoid architecture are poorly defined. During a 2021–2022 rabies virus (RABV) outbreak in South Africa, we collected cervical lymph nodes from 36 rabies-suspect dogs; RABV RNA was detected in 27. Canine distemper virus RNA was detected in a subset across both RABV-positive (RABV+) and RABV-negative (RABV−) groups and was not associated with clinical-sign count. We set up a computer-assisted histological analysis tool to quantify germinal-centre (GC) nucleus density and immunohistochemistry for CD20, PNA and IBA1 to profile B cells, GC activity and macrophages. Within the outbreak cohort, GC density and marker-based metrics did not differ between RABV+ and RABV− dogs. Two healthy dogs were included as reference tissues; values in outbreak dogs were generally lower, but these contrasts are contextual given the limited, non-matched controls. This study provides a reproducible framework for quantifying immune cell organization in field-collected tissues during natural RABV exposure and highlights the need for larger, geographically matched control groups and complementary functional immune measurements.
- 6 November 2025
- Published by Microbiology Society in Journal of General Virology
- Vol. 106 (11) , 002166
Open AccessImmunohistochemical investigation of canine lymph nodes collected during a rabies outbreak in South Africa
Rabies is a fatal zoonosis that impairs host immune function, yet effects on peripheral lymphoid architecture are poorly defined. During a 2021–2022 rabies virus (RABV) outbreak in South Africa, we collected cervical lymph nodes from 36 rabies-suspect dogs; RABV RNA was detected in 27. Canine distemper virus RNA was detected in a subset across both RABV-positive (RABV+) and RABV-negative (RABV−) groups and was not associated with clinical-sign count. We set up a computer-assisted histological analysis tool to quantify germinal-centre (GC) nucleus density and immunohistochemistry for CD20, PNA and IBA1 to profile B cells, GC activity and macrophages. Within the outbreak cohort, GC density and marker-based metrics did not differ between RABV+ and RABV− dogs. Two healthy dogs were included as reference tissues; values in outbreak dogs were generally lower, but these contrasts are contextual given the limited, non-matched controls. This study provides a reproducible framework for quantifying immune cell organization in field-collected tissues during natural RABV exposure and highlights the need for larger, geographically matched control groups and complementary functional immune measurements.
- Open Access
- 7 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
Extracellular vesicles (EVs) play a crucial role in intercellular communication by transferring bioactive molecules from donor to recipient cells. As a result, EV fusion leads to the modulation of cellular functions and has an impact on both physiological and pathological processes in the recipient cell. This study explores the impact of EV fusion on cellular responses to inflammatory signaling. Our findings reveal that fusion renders non-responsive cells susceptible to inflammatory signaling, as evidenced by increased NF-κB activation and the release of inflammatory mediators. Syntaxin-binding protein 1 is essential for the merge and activation of intracellular signaling. Subsequent analysis show that EVs transfer their functionally active receptors to target cells, making them prone to an otherwise unresponsive state. EVs in complex with their agonist, require no further stimulation of the target cells to trigger mobilization of NF-κB. While receptor antagonists were unable to inhibit NF-κB activation, blocking of the fusion between EVs and their target cells with heparin mitigated inflammation in mice challenged with EVs.
- 7 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessThe role of extracellular vesicle fusion with target cells in triggering systemic inflammation
Extracellular vesicles (EVs) play a crucial role in intercellular communication by transferring bioactive molecules from donor to recipient cells. As a result, EV fusion leads to the modulation of cellular functions and has an impact on both physiological and pathological processes in the recipient cell. This study explores the impact of EV fusion on cellular responses to inflammatory signaling. Our findings reveal that fusion renders non-responsive cells susceptible to inflammatory signaling, as evidenced by increased NF-κB activation and the release of inflammatory mediators. Syntaxin-binding protein 1 is essential for the merge and activation of intracellular signaling. Subsequent analysis show that EVs transfer their functionally active receptors to target cells, making them prone to an otherwise unresponsive state. EVs in complex with their agonist, require no further stimulation of the target cells to trigger mobilization of NF-κB. While receptor antagonists were unable to inhibit NF-κB activation, blocking of the fusion between EVs and their target cells with heparin mitigated inflammation in mice challenged with EVs.